Faruk Sinangil

Global Solutions for Infectious Diseases — United States

Immunology and Microbiology · Life Sciences

35h-index5.2kcitations90works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(65), HIV/AIDS drug development and treatment(21), Immune Cell Function and Interaction(20), Monoclonal and Polyclonal Antibodies Research(18), Hepatitis C virus research(13)

Publications89 total

Vaccine Induced Seroreactivity Following Administration of ALVAC-HIV/AIDSVAX®B/E Identified by Common Anti-HIV Test Kits and Algorithms in Thailand
Open Forum Infectious Diseases·2025Open Access
Impact of Human Leukocyte Antigen Allele–Killer Cell Immunoglobulin-like Receptor Partners on Sexually Transmitted Human Immunodeficiency Virus Type 1 Infection
The Journal of Infectious Diseases·2024· 1 citedOpen Access
Innate immune cell activation after HIV-1 vaccine administration is associated with increased antibody production
Frontiers in Immunology·2024· 3 citedOpen Access
Additional boosting to the RV144 vaccine regimen increased Fc-mediated effector function magnitude but not durability
AIDS·2023· 13 citedOpen Access
ALVAC-HIV and AIDSVAX B/E vaccination induce improved immune responses compared with AIDSVAX B/E vaccination alone
JCI Insight·2023· 6 citedOpen Access
Army Liposome Formulation Augments the Immunogenicity of HIV-1 AIDSVAX® B/E Protein
The Journal of Immunology·2023Open Access
No association of a risk variant for severe COVID-19 with HIV protection in three cohorts of highly exposed individuals
PNAS Nexus·2022· 2 citedOpen Access
<i>IFNL4</i> genotype influences the rate of HIV-1 seroconversion in men who have sex with men
Virulence·2022Open Access
AIDSVAX protein boost improves breadth and magnitude of vaccine-induced HIV-1 envelope-specific responses after a 7-year rest period
Vaccine·2021· 2 citedOpen Access
Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trial
The Lancet HIV·2020· 46 citedOpen Access
HIV vaccine delayed boosting increases Env variable region 2–specific antibody effector functions
JCI Insight·2020· 27 citedOpen Access
Boosting with AIDSVAX B/E Enhances Env Constant Region 1 and 2 Antibody-Dependent Cellular Cytotoxicity Breadth and Potency
Journal of Virology·2019· 23 citedOpen Access
Association of complement C3d receptor 2 genotypes with the acquisition of HIV infection in a trial of recombinant glycoprotein 120 vaccine
AIDS·2019· 10 cited
DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trial
Journal of Clinical Investigation·2019· 36 citedOpen Access
Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa
Science Translational Medicine·2019· 68 citedOpen Access
Boosting with ALVAC-HIV and AIDSVAX B/E enhances Env constant region 1 and 2 antibody-dependent cellular cytotoxicity
2019· 3 citedOpen Access
Ancestral sequences from an elite neutralizer proximal to the development of neutralization resistance as a potential source of HIV vaccine immunogens
PLoS ONE·2019· 6 citedOpen Access
Late Boosting of the RV144 Regimen Improves the Magnitude and Quality of Immune Responses
SSRN Electronic Journal·2019Open Access
Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations
PLoS ONE·2018· 17 citedOpen Access
Functional Antibody Response Against V1V2 and V3 of HIV gp120 in the VAX003 and VAX004 Vaccine Trials
Scientific Reports·2018· 30 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Phillip W. Berman(17), Nelson L. Michael(16), David C. Montefiori(15), Sorachai Nitayaphan(14), Jaranit Kaewkungwal(14), Supachai Rerks‐Ngarm(13), Punnee Pitisuttithum(13), Jérôme H. Kim(13), Georgia D. Tomaras(13), Merlin L. Robb(13), James Tartaglia(12), Susan Zolla‐Pazner(11), Peter B. Gilbert(9), Barton F. Haynes(9), Robert J. O’Connell(8), Donald P. Francis(8), Sanjay Phogat(8), Jean‐Louis Excler(8), David J. Volsky(8), S. Munir Alam(7)